Drug recall · September 13, 2017
Latanoprost PF Solution recall
Why: Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Latanoprost PF Solution, 0.005%, Ophthalmic Drops in Sterile 5ml Bottles, Compounded for a licensed professional or patient use, imprimisRx, Irvine, CA
- Lots / codes
0404017@32B, 10/01/2017
- Quantity
- 19 bottles
- Company
- ImprimisRx CA, Inc., dba ImprimisRx, Irvine, CA
- Distribution
- Nationwide
- Initiated
- June 23, 2017 · Voluntary: Firm initiated
- Classified
- September 7, 2017
- Reported
- September 13, 2017
- Ended
- January 14, 2019
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Latanoprost
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.